B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,183 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 102
Growth YoY: +1.5%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 751–800 of 2,959 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03990961	Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)	terminated	Phase 2	5	University of ChicagoOTHER	1	Feb 20, 2026	clinicaltrials
NCT04282018	Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab	completed	Phase 1 / Phase 2	97	BeiGeneINDUSTRY	2	Feb 20, 2026	clinicaltrials
NCT04421560